2m 2m 2m 2m 2m 2m 2m
NIKA PHARMA (NIKA)
OTC
$0.51+$0.30 (+140.23%)
Price as of Aug 03, 2026- $806.3MMarket Cap
- -46.20%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
NIKA PHARMA (NIKA)
$0.51+$0.30 (+140.23%)
NIKA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.51 | ||
Change | +$0.30 (+140.23%) | ||
Open | $0.97 | ||
High | $0.97 | ||
Low | $0.51 | ||
Previous Close | $0.21 | ||
Volume | 1,650 | ||
30-Day Average Volume | 875 | ||
1-Week Change | -33.68% | ||
1-Month Change | -33.68% | ||
1-Year Change | -46.20% | ||
3-Year Change | -36.33% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.0B | ||
Total Assets | $20,637.00 | ||
Market Cap | $806.3M | ||
Enterprise Value | $806.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13,359.00 | ||
Free Cash Flow | -$13,359.00 | ||
EBIT | -$13,359.00 | ||
EBITDA | -$13,359.00 | ||
Net Working Capital | -$310,987.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -60,384 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -60,359 | ||
Price/Operating Cash Flow | -60,359 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||